Literature DB >> 17574839

Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.

Pål Møller1, Anne Irene Hagen, Jaran Apold, Lovise Maehle, Neal Clark, Bent Fiane, Kjell Løvslett, Eivind Hovig, Anita Vabø.   

Abstract

Ten BRCA mutations were demonstrated to be frequent in the Norwegian population. We present maps verifying the uneven distribution of prevalences according to municipality. We tested incident breast cancer cases treated in Mid-Norway from 1999 onwards for these mutations. Uptake of testing was 97% and 2.5% were demonstrated to be mutation carriers. Ten (77%) were outside families previously known to carry a mutation. Ten (77%) did not meet clinical criteria to be selected for mutation testing. We tested incident ovarian cancer cases in South-West Norway from 2001 onwards. Uptake of testing was 80% and 23% were mutation carriers. Twenty-one (88%) were outside families previously known. Twelve (67%) did not meet clinical criteria to be selected for testing. All patients with mutation collaborated actively to give our offer of predictive genetic testing to their relatives. No complaint on the activity was received.

Entities:  

Mesh:

Year:  2007        PMID: 17574839     DOI: 10.1016/j.ejca.2007.04.023

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  49 in total

1.  Next-generation sequencing for cancer diagnostics: a practical perspective.

Authors:  Cliff Meldrum; Maria A Doyle; Richard W Tothill
Journal:  Clin Biochem Rev       Date:  2011-11

Review 2.  The role of BRCA mutation testing in determining breast cancer therapy.

Authors:  Alison H Trainer; Craig R Lewis; Kathy Tucker; Bettina Meiser; Michael Friedlander; Robyn L Ward
Journal:  Nat Rev Clin Oncol       Date:  2010-11-09       Impact factor: 66.675

3.  Electronically ascertained extended pedigrees in breast cancer genetic counseling.

Authors:  V Stefansdottir; H Skirton; O Th Johannsson; H Olafsdottir; G H Olafsdottir; L Tryggvadottir; J J Jonsson
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

Review 4.  Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance.

Authors:  Katsutoshi Oda; Michihiro Tanikawa; Kenbun Sone; Mayuyo Mori-Uchino; Yutaka Osuga; Tomoyuki Fujii
Journal:  Int J Clin Oncol       Date:  2017-05-15       Impact factor: 3.402

5.  Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.

Authors:  Bettina Meiser; Veronica F Quinn; Gillian Mitchell; Kathy Tucker; Kaaren J Watts; Belinda Rahman; Michelle Peate; Christobel Saunders; Elizabeth Geelhoed; Margaret Gleeson; Kristine Barlow-Stewart; Michael Field; Marion Harris; Yoland C Antill; Rachel Susman; Michael T Bowen; Llew Mills; Judy Kirk
Journal:  Eur J Hum Genet       Date:  2018-03-30       Impact factor: 4.246

6.  Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

Authors:  Kari Nyheim Solbrække; Håvard Søiland; Kirsten Lode; Birgitta Haga Gripsrud
Journal:  Med Health Care Philos       Date:  2017-03

7.  CK8/18 expression, the basal phenotype, and family history in identifying BRCA1-associated breast cancer in the Ontario site of the breast cancer family registry.

Authors:  Anna Marie Mulligan; Dushanthi Pinnaduwage; Anita L Bane; Shelley B Bull; Frances P O'Malley; Irene L Andrulis
Journal:  Cancer       Date:  2010-11-02       Impact factor: 6.860

8.  High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series.

Authors:  Pål Møller; Lovise Mæhle; Lars F Engebretsen; Trond Ludvigsen; Christoffer Jonsrud; Jaran Apold; Anita Vabø; Neal Clark
Journal:  Hered Cancer Clin Pract       Date:  2010-01-19       Impact factor: 2.857

9.  Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk.

Authors:  D Gareth R Evans; Richard Clayton; Paul Donnai; Andrew Shenton; Fiona Lalloo
Journal:  Eur J Hum Genet       Date:  2009-04-15       Impact factor: 4.246

Review 10.  Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.

Authors:  Bettina Meiser; Kathy Tucker; Michael Friedlander; Kristine Barlow-Stewart; Elizabeth Lobb; Christobel Saunders; Gillian Mitchell
Journal:  Breast Cancer Res       Date:  2008-11-28       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.